Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Allison N Casey"'
Autor:
Yang Wu, Zheqi Li, Abdalla M. Wedn, Allison N. Casey, Daniel Brown, Shalini V. Rao, Soleilmane Omarjee, Jagmohan Hooda, Jason S. Carroll, Jason Gertz, Jennifer M. Atkinson, Adrian V. Lee, Steffi Oesterreich
Publikováno v:
Molecular Cancer Research. 21:591-604
Estrogen receptor alpha (ER/ESR1) mutations occur in 30% to 40% of endocrine resistant ER-positive (ER+) breast cancer. Forkhead box A1 (FOXA1) is a key pioneer factor mediating ER–chromatin interactions and endocrine response in ER+ breast cancer,
Abstract P6-14-02: Hope for OTHERS – An organ donation program for metastatic breast cancer research
Autor:
Steffi Oesterreich, Lori Miller, Margaret Q. Rosenzweig, Tanner L. Bartholow, Megan Yates, Ashuvinee Elangovan, Laura Savariau, Allison N. Casey, Nolan Priedigkeit, Kai Ding, Abdalla Wedn, Jie Bin Liu, Daniel D. Brown, Tara Hyder, Geoffrey Pecar, Neil Carleton, Humberto Trejo Bittar, Daniel Geisler, Oscar Lopez-Nunez, Amanda M. Clark, Alan Wells, Partha Roy, Shannon Puhalla, Naomi Howard, Christine Needles, Susan Trent, Stephanie Walker, Christine Hodgdon, Rohit Bhargava, Jennifer M. Atkinson, Adrian V. Lee
Publikováno v:
Cancer Research. 83:P6-14
Background: Previous studies have shown that rapid autopsies (RA) provide a unique opportunity for tissue collection from patients who succumb to the disease. Because cancer patients are unable to donate their organs to other people, this program pro
Autor:
Steffi Oesterreich, Adrian V. Lee, Jennifer M. Atkinson, Jason Gertz, Jason S. Carroll, Jagmohan Hooda, Soleilmane Omarjee, Shalini V. Rao, Daniel Brown, Allison N. Casey, Abdalla M. Wedn, Zheqi Li, Yang Wu
Estrogen receptor alpha (ER/ESR1) mutations occur in 30% to 40% of endocrine resistant ER-positive (ER+) breast cancer. Forkhead box A1 (FOXA1) is a key pioneer factor mediating ER–chromatin interactions and endocrine response in ER+ breast cancer,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12a2ed57172cf4dc081f4403648a1e2b
https://doi.org/10.1158/1541-7786.c.6573877.v1
https://doi.org/10.1158/1541-7786.c.6573877.v1
Autor:
Steffi Oesterreich, Adrian V. Lee, Jennifer M. Atkinson, Jason Gertz, Jason S. Carroll, Jagmohan Hooda, Soleilmane Omarjee, Shalini V. Rao, Daniel Brown, Allison N. Casey, Abdalla M. Wedn, Zheqi Li, Yang Wu
S1. FOXA1 redistribution in ESR1 mutant cells causes distinct ER-FOXA1 interaction.S2. FOXA1 gained peaks annotated genes are significantly associated with novel target genes.S3. FOXA1 redistribution in ESR1 mutant cells confers potential RXR binding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c12d03baf664d3111b46bf66e4ed650
https://doi.org/10.1158/1541-7786.22593319.v1
https://doi.org/10.1158/1541-7786.22593319.v1
Autor:
Steffi Oesterreich, Adrian V. Lee, Jennifer M. Atkinson, Jason Gertz, Jason S. Carroll, Jagmohan Hooda, Soleilmane Omarjee, Shalini V. Rao, Daniel Brown, Allison N. Casey, Abdalla M. Wedn, Zheqi Li, Yang Wu
Table S1. Data Sets UsedTable S2. FOXA1 and ER Chip-seq peaksTable S3. DE genesTable S4. Enriched FOXA1 peak motifsTable S5. Enriched IPA pathways
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7b12dbdcef5cd2915b6960559f5049c
https://doi.org/10.1158/1541-7786.22593316
https://doi.org/10.1158/1541-7786.22593316
Autor:
Gerald V. Denis, Naser Jafari, Charlotte Smith, Anna C. Belkina, Allison N Casey, Guillaume Andrieu, Jordan S. Shafran
Publikováno v:
Cancer Lett
Therapeutic strategies aiming to leverage anti-tumor immunity are being intensively investigated as they show promising results in cancer therapy. The PD-1/PD-L1 pathway constitutes an important target to restore functional anti-tumor immune response
Autor:
Gerald V. Denis, Allison N Casey, Tova Meshulam, Yuhan Qiu, Manohar Kolla, Christina S Ennis, Nabil Rabhi, Jordan S. Shafran, Stephen R. Farmer, Carla Mazzeo, Naser Jafari, Isabella R Pompa
Publikováno v:
Sci Signal
Obesity and metabolic diseases, such as insulin resistance and type 2 diabetes (T2D), are associated with metastatic breast cancer in post-menopausal women. Here, we investigated the critical cellular and molecular factors behind this link. We found
Publikováno v:
Prostate cancer and prostatic diseases
Background Androgen deprivation therapies for the hormone-dependent stages of prostate cancer have become so effective that new forms of chemoresistant tumors are emerging in clinical practice, and require new targeted therapies in the metastatic set